My Opinion of poof's Opinion of Chiesi's CHMP OpinionPoof reports that Chiesi has received an opinion, not an approval, an opinion, from CHMP. My opinion is that the opinion makes a thin soup. Approvals make positively hearty soups, fattening, even. It's also my opinion that poof's opinion about the CHMP opinion seems a little over the top, especially when he's still pumping the M&M, the Midatech "Merger".
Basically, in my opinion, poof has written an opinion about a CHMP opinion of a drug that isn't even an xB3 drug, won't be one for a year or two, and has a value placed on it by Bioasis of only $750,000.
It's also interesting to me that poof says Bioasis has indicated that Hunter data would have been released shortly after Biodexa got going after the "merger".
How about serving up that data right now, for Bioasis. I've opined for months that Bioasis may be holding back news, maybe even holding off business deals, until the "merger" gets done.
Meanwhile, opinions about opinions about LSDs worth only $750,000 each aren't worth much.
But a little xB3 data right about now might begin to make the case that xB3 has more value than Rathjen has been acknowledging this past year. Bioasis shareholders could use a little truth about xB3 these days.
I like xB3 data far more than I like opinions about opinions offered up to pump a losing "merger".
And that's my opinion about poof"s opinion about CHMP's opinion.
Show us the data! Now!
jd